目錄:MedChemExpress LLC>>生化試劑>> 5Z-7-Oxozeaenol | MCE
CAS | 253863-19-3 | 純度 | 99.60% |
---|---|---|---|
分子量 | 362.37 | 分子式 | C??H??O? |
供貨周期 | 現(xiàn)貨 | 貨號 | HY-12686 |
應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 253863-19-3
產(chǎn)品活性:5Z-7-Oxozeaenol is a natural anti-protozoan compound from fungal origin, acting as a potent irreversible and selective inhibitor of TAK1 and VEGF-R2, with IC50s of 8 nM and 52 nM, respectively.
研究領(lǐng)域:MAPK/ERK Pathway | Protein Tyrosine Kinase/RTK | Anti-infection
作用靶點:MAP3K | VEGFR | Antibiotic
結(jié)構(gòu)分類:酚類 | 單酚類 | 其他類 | 結(jié)構(gòu)分類
In Vitro: 5Z-7-Oxozeaenol is a potent irreversible and selective inhibitor of transforming growth factor (TGF)-β-activated kinase 1 (TAK1, IC50, 8.1 nM), less active on MEK1 (IC50, 411 nM). 5Z-7-Oxozeaenol prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. 5Z-7-Oxozeaenol is also an inhibitor of VEGF-R2, with an IC50 of 52 nM. 5Z-7-Oxozeaenol has inhibitory activity against VEGF-R3, FLT3, PDGFR-β, B-RAF VE and SRC, with IC50s of 110, 170, 340, 6300 and 6600 nM, respectively. 5Z-7-Oxozeaenol inhibits JNK/p38 paythway, but it is not a direct inhibitor and is signal specific. 5Z-7-Oxozeaenol suppresses the PMA-induced AP-1 activity almost to the basal level in the KT cells, but has no effects on IL-1-induced NF-kB activity in the KK cells.
相關(guān)產(chǎn)品:Natural Product Library Plus | Bioactive Compound Library Plus | Macrocyclic Compound Library | (1R,2S,7R)-Sitafloxacin-d4 (hydrochloride) | 5α-Hydroxycostic acid | Doxorubicin-13C,d3 (TFA) | GW806742X hydrochloride | Antibiotic A-33853 | Sulbactam-d2 (sodium) | Azlocillin sodium salt | Toyocamycin | Sorafenib-d4 | Hispolon | SPR206 acetate | Doxycycline calcium | BMS-690514 | Staurosporine | Dihydrostreptomycin sulfate | WX-081 | SQ109 | Neomycin sulfate | Concanavalin A | Framycetin | Colistin sulfate | Amphotericin A | L-Lactic acid-2-13C1 | Griseofulvin-d3 | Monensin sodium salt | VEGFR-2-IN-6 | PROTAC VEGFR-2 degrader-1 | (R)-10,11-Dehydrocurvularin | (R)-Ofloxacin-d3 | Cefadroxil-d4 (hydrate)
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作。